SLC22A5 and hepatocellular carcinoma: Hepatocellular carcinoma (HCC), the fourth most common cause of cancer-related death worldwide, poses a significant global healthcare challenge.293 Yang et al. found that organic cation/carnitine transporter 2 (OCTN2) is significantly elevated in HCC and has a strong association with poor prognosis.